Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: A Korean Gynecologic Oncology Group study

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 2, 2013, Pages 304-310

  Lee, Taek Sang ^a   Kang, Soon Beom ^b   Kim, Young Tak ^c   Park, Byung Joo ^d   Kim, Yong Man ^c   Lee, Jong Min ^e   Kim, Seok Mo ^f   Kim, Young Tae ^g   Kim, Jae Hoon ^h   Kim, Kyung Tai ⁱ  

^a Seoul National University Boramae Hospital   (South Korea)

^b Konkuk University Hospital   (South Korea)

^c Asan Medical Center   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e Kyung Hee University College of Medicine   (South Korea)

^f Chonnam National University Medical School   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

ⁱ Hanyang University Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVES; CONCURRENT CHEMORADIATION; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; METHODS AND MATERIALS; MULTIVARIABLE ANALYSIS; NONHEMATOLOGIC TOXICITY; OVERALL SURVIVAL RATES;

CHEMORADIOTHERAPY; POPULATION STATISTICS; TOXICITY;

GYNECOLOGY;

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ALLERGIC REACTION; ALOPECIA; ANEMIA; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONSTIPATION; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; INTENTION TO TREAT ANALYSIS; LIVER DISEASE; LYMPH NODE; MAJOR CLINICAL STUDY; MALAISE; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE RISK; RISK ASSESSMENT; THROMBOCYTOPENIA; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; CARBOPLATIN; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; REPUBLIC OF KOREA; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84877283986     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.01.035     Document Type: Article

References (20)

1. H.M. Keys, B.N. Bundy, and F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
2. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
3. W.A. Peters 3rd, P.Y. Liu, and R.J. Barrett 2nd Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
4. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
5. C.W. Whitney, W. Sause, and B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
6. L. Cetina, L. Rivera, and J. Hinojosa Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results BMC Womens Health 6 2006 3
7. A. Brock, W. Prager, and R. Bohme [The methods and results of simultaneous radiochemotherapy with carboplatin in advanced cervical carcinomas] Strahlenther Onkol 170 1994 264 268
8. D.H. Moore, J.A. Blessing, and R.P. McQuellon Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study J Clin Oncol 22 2004 3113 3119
9. M. Hosaka, H. Watari, and T. Kato Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy J Surg Oncol 105 2012 612 616
10. G.G. Rao, P. Rogers, and R.D. Drake Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer Gynecol Oncol 96 2005 168 172
11. R. Higgins, M. Bussey, and W. Naumann Concurrent carboplatin and paclitaxel with pelvic radiation therapy in the primary treatment of cervical cancer Am J Obstet Gynecol 197 2007 205 e201-e205; discussion 205, e205-e207
12. K. Kim, E.K. Chie, and H.G. Wu Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer Gynecol Oncol 101 2006 398 402
13. Whitney CW, Spirtos N. Gynecologic Oncology Group Surgical Procedures Manual. 2005 January. Available at: https://gogmember.gog.org/manuals/pdf/ surgman.pdf. Accessed July 1, 2005.
14. A.H. Calvert, D.R. Newell, and L.A. Gumbrell Carboplatin dosage: Prospective evaluation of a simple formula based on renal function J Clin Oncol 7 1989 1748 1756
15. T. Thigpen, R.B. Vance, and T. Khansur The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix Semin Oncol 22 1995 67 75
16. F.Y. de Vos, A.M. Bos, and J.A. Gietema Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer Anticancer Res 24 2004 345 348
17. S.Y. Ryu, W.M. Lee, and K. Kim Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer Int J Radiat Oncol Biol Phys 81 2011 e577 e581
18. W.Y. Kim, S.J. Chang, and K.H. Chang Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification J Gynecol Oncol 20 2009 17 21
19. Y. Aoki, M. Sasaki, and M. Watanabe High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation Gynecol Oncol 77 2000 305 309
20. S.A. Yeh, S. Wan Leung, and C.J. Wang Postoperative radiotherapy in early stage carcinoma of the uterine cervix: Treatment results and prognostic factors Gynecol Oncol 72 1999 10 15